Benjamin D. Leibowitz
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- Cancer Genomics and Diagnostics 2
- Cancer, Hypoxia, and Metabolism 1
- Oncology 4
- Cancer Cells and Metastasis 1
- Cancer Immunotherapy and Biomarkers 1
- Cancer-related Molecular Pathways 1
- PARP inhibition in cancer therapy 1
- Co-authors
- Nike Beaubier (2 shared papers)Joshua S. K. Bell (2 shared papers)Catherine Igartua (2 shared papers)Jackson K. Michuda (1 shared paper)Andrew J. Sedgewick (1 shared paper)Timothy Taxter (1 shared paper)Jonathan R. Dry (1 shared paper)Bonnie V. Dougherty (1 shared paper)
- Journals
- Cell Reports (1 paper)Clinical Breast Cancer (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)Nature Biotechnology (1 paper)BMC Cancer (1 paper)
- Partner nations
- United States
In The Last Decade
Benjamin D. Leibowitz
6 papers receiving 275 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 85
- Oncology 131
- Health Informatics 4
- Biophysics 11
- Pulmonary and Respiratory Medicine 41
Countries citing papers authored by Benjamin D. Leibowitz
This map shows the geographic impact of Benjamin D. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin D. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin D. Leibowitz more than expected).
Fields of papers citing papers by Benjamin D. Leibowitz
This network shows the impact of papers produced by Benjamin D. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin D. Leibowitz. The network helps show where Benjamin D. Leibowitz may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin D. Leibowitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 143 | |
| 2 | 2021 | 81 | |
| 3 | 2022 | 40 | |
| 4 | 2020 | 16 | |
| 5 | 2023 | 1 | |
| 6 | 2025 | 1 |
About Benjamin D. Leibowitz
Benjamin D. Leibowitz is a scholar working on Cancer Research, Oncology, Bioengineering, Genetics and Molecular Biology, having authored 6 papers that have together received 282 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Cancer Cells and Metastasis (1 paper), Analytical Chemistry and Sensors (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Cancer-related Molecular Pathways (1 paper), PARP inhibition in cancer therapy (1 paper), Virus-based gene therapy research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (85 citations), Oncology (131 citations), Health Informatics (4 citations), Biophysics (11 citations) and Pulmonary and Respiratory Medicine (41 citations). Benjamin D. Leibowitz has collaborated with scholars based in United States. Frequent co-authors include Nike Beaubier, Joshua S. K. Bell, Catherine Igartua, Jackson K. Michuda, Andrew J. Sedgewick, Timothy Taxter, Jonathan R. Dry, Bonnie V. Dougherty, Ashraf Hafez and Ameen Abdulla Salahudeen. Their work appears in journals such as Cell Reports, Clinical Breast Cancer, International Journal of Radiation Oncology*Biology*Physics, Nature Biotechnology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.